ArticleOpen forum infectious diseases2025
HIV, STI, and Hepatitis Among People Who Inject Drugs at a Sexual Health Clinic in Melbourne, Australia: 2012 to 2022.
Article in Open forum infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aimed to examine the sexual practices and sexually transmitted infection (STI) positivity among people who inject drugs (PWID). Methods: This was a repeated cross-sectional study analyzing data collected at a sexual health center during 2012-2022. New clients who were aged 18 and older, sexually active, and had injected drugs in the last 12 months were eligible for inclusion. Clients were categorized as men who have sex with women only (MSWO), gay or bisexual men who have sex with men (gbMSM), or women. We calculated the 2-year positivity of HIV, STIs, hepatitis B virus (HBV), and hepatitis C virus (HCV), and temporal analyses were conducted using the chi-square trend test. Results: A total of 1229 clients (395 MSWO, 457 gbMSM, and 377 women) were included in the study. There was a significant rise in syphilis ( Conclusions: PWID are highly susceptible to STIs and blood-borne infections. Future prevention programs directed at PWID must include increasing the rate of HCV testing and messages related to sexual risk practices to help reduce the burden of disease in PWID.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.